Literature DB >> 22189657

Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.

Arne Nagels1, André Kirner-Veselinovic, Richard Wiese, Frieder M Paulus, Tilo Kircher, Sören Krach.   

Abstract

The N-methyl-D-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. Administered to healthy individuals, a subanesthetic dose of the noncompetitive NMDAR antagonist ketamine reproduces several psychopathological symptoms commonly observed in patients with schizophrenia. In a counterbalanced, placebo-controlled, double-blind, within-participants study, fifteen healthy subjects were administered a continuous subanesthetic S-ketamine infusion while cortical activation was measured using functional magnetic resonance imaging. While being scanned, subjects performed an overt word generation task. Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine administration elicited effects on psychopathology, including difficulties in abstract thinking, lack of spontaneity and flow of conversation as well as formal thought disorder. On a behavioral level, verbal fluency performance was unaffected. The PANSS score for formal thought disorder positively correlated with activation measures encompassing the left superior temporal gyrus, the right middle and inferior frontal gyrus and the precuneus. Difficulty in abstract thinking was correlated with pronounced activations in prefrontal as well as in anterior cingulate regions, whereas hyperactivations in the left superior temporal gyrus were found in association with a lack of spontaneity and flow of conversation. In the absence of behavioral impairments during verbal fluency, NMDAR blocking evoked psychopathological symptoms and cortical activations in regions previously reported in schizophrenia patients. The results provide further support for the hypothesis of an NMDAR dysfunction in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189657     DOI: 10.1007/s00406-011-0281-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  68 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers.

Authors:  B M DAVIES; H R BEECH
Journal:  J Ment Sci       Date:  1960-07

3.  Neural correlates of rhyming vs. lexical and semantic fluency.

Authors:  Tilo Kircher; Arne Nagels; André Kirner-Veselinovic; Sören Krach
Journal:  Brain Res       Date:  2011-03-27       Impact factor: 3.252

4.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

Authors:  A Breier; A K Malhotra; D A Pinals; N I Weisenfeld; D Pickar
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

5.  Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia.

Authors:  Michal Assaf; Paul R Rivkin; Cheedem H Kuzu; Vince D Calhoun; Michael A Kraut; Karyn M Groth; Michael A Yassa; John Hart; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2005-09-30       Impact factor: 13.382

6.  Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study.

Authors:  T T Kircher; P F Liddle; M J Brammer; S C Williams; R M Murray; P K McGuire
Journal:  Arch Gen Psychiatry       Date:  2001-08

7.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

8.  Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.

Authors:  Cynthia H Y Fu; Kathryn M Abel; Matthew P G Allin; David Gasston; Sergi G Costafreda; John Suckling; Steve C R Williams; Philip K McGuire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

Review 9.  Organization of cognitive control within the lateral prefrontal cortex in schizophrenia.

Authors:  Guillaume Barbalat; Valerian Chambon; Nicolas Franck; Etienne Koechlin; Chlöé Farrer
Journal:  Arch Gen Psychiatry       Date:  2009-04

10.  Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice.

Authors:  Sijie Tan; John A Rudd; David T Yew
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

View more
  10 in total

Review 1.  Neural correlates of formal thought disorder: An activation likelihood estimation meta-analysis.

Authors:  Tobias Wensing; Edna C Cieslik; Veronika I Müller; Felix Hoffstaedter; Simon B Eickhoff; Thomas Nickl-Jockschat
Journal:  Hum Brain Mapp       Date:  2017-06-27       Impact factor: 5.038

Review 2.  Recent insights into the mode of action of memantine and ketamine.

Authors:  Jon W Johnson; Nathan G Glasgow; Nadezhda V Povysheva
Journal:  Curr Opin Pharmacol       Date:  2014-12-02       Impact factor: 5.547

Review 3.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

4.  Effects of ketamine on brain function during smooth pursuit eye movements.

Authors:  M Steffens; B Becker; C Neumann; A M Kasparbauer; I Meyhöfer; B Weber; M A Mehta; R Hurlemann; U Ettinger
Journal:  Hum Brain Mapp       Date:  2016-11       Impact factor: 5.038

5.  Ketamine-Induced Hallucinations.

Authors:  Albert R Powers; Mark G Gancsos; Emily S Finn; Peter T Morgan; Philip R Corlett
Journal:  Psychopathology       Date:  2015-09-12       Impact factor: 1.944

6.  S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.

Authors:  Arne Nagels; Maurice Cabanis; Andrea Oppel; Andre Kirner-Veselinovic; Christian Schales; Tilo Kircher
Journal:  Neuropsychopharmacology       Date:  2017-11-06       Impact factor: 7.853

7.  Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

Authors:  Georges Mion; Thierry Villevieille
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

8.  Biomarkers and neurobiology of schizophrenia.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08       Impact factor: 5.270

Review 9.  Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.

Authors:  Moritz Haaf; Gregor Leicht; Stjepan Curic; Christoph Mulert
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

10.  Neurobiological substrates of the positive formal thought disorder in schizophrenia revealed by seed connectome-based predictive modeling.

Authors:  Ji Chen; Tobias Wensing; Felix Hoffstaedter; Edna C Cieslik; Veronika I Müller; Kaustubh R Patil; André Aleman; Birgit Derntl; Oliver Gruber; Renaud Jardri; Lydia Kogler; Iris E Sommer; Simon B Eickhoff; Thomas Nickl-Jockschat
Journal:  Neuroimage Clin       Date:  2021-04-30       Impact factor: 4.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.